Suchergebnisse - "Richter, Joshua"

PubPharm (81)

1

Soluble B-cell maturation antigen in multiple myeloma

enthalten in: American journal of hematology | 2024

von Costa, B. | Ortiz, R. | Lesokhin, A. | +1

2

Practical Aspects of Immunotherapy : A Report from the 20th International Myeloma Society (IMS) Annual Meeting

enthalten in: Clinical lymphoma, myeloma & leukemia | 2024

von Raje, N. | Cohen, A. | Patel, K. | +3

3

Thromboembolic risk of carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for newly diagnosed multiple myeloma : A comparative systematic review and meta-analysis

enthalten in: American journal of hematology | 2024

von Costa, B. | Costa, T. | Saravia, S. | +4

4

T-cell redirection therapy after allogeneic stem cell transplantation in multiple myeloma : When the cure fails!

enthalten in: British journal of haematology | 2024

von Richter, J.

5

Carfilzomib, daratumumab, and dexamethasone (KdD) vs. lenalidomide-sparing pomalidomide-containing triplet regimens for relapsed/refractory multiple myeloma : an indirect treatment comparison

enthalten in: Leukemia & lymphoma | 2024

von Weisel, K. | Dimopoulos, M. | Beksac, M. | +7

6

Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups

enthalten in: Blood advances | 2024

von Shah, U. | Moshier, E. | Derkach, A. | +20

CommentIn: Blood Adv. 2024 Jan 9;8(1):234-235. - PMID 38194241

7

In-class transition from bortezomib-based therapy to IRd is an effective approach in newly diagnosed multiple myeloma

enthalten in: Future oncology (London, England) | 2024

von Rifkin, R. | Costello, C. | Birhiray, R. | +11

8

Cellular mechanisms associated with sub-optimal immune responses to SARS-CoV-2 bivalent booster vaccination in patients with Multiple Myeloma

enthalten in: EBioMedicine | 2023

von Aleman, A. | van Kesteren, M. | Zajdman, A. | +46

9

Real-world multiple myeloma front-line treatment and outcomes by transplant in the United States

enthalten in: EJHaem | 2023

von Richter, J. | Pan, D. | Salinardi, T. | +1

10

IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies

enthalten in: Blood cancer discovery | 2023

von Lancman, G. | Parsa, K. | Kotlarz, K. | +13

CommentIn: Blood Cancer Discov. 2023 Nov 1;4(6):427-429. - PMID 37769160

1
2
3
4
5
6
7
8
9
Nächster »
[9]